Mazor Robotics Ltd. (NASDAQ:MZOR) to Release Earnings on Tuesday
Mazor Robotics Ltd. (NASDAQ:MZOR) is scheduled to post its quarterly earnings results before the market opens on Tuesday, August 1st. Analysts expect Mazor Robotics to post earnings of ($0.25) per share for the quarter.
Mazor Robotics (NASDAQ:MZOR) last released its quarterly earnings results on Wednesday, May 10th. The medical instruments supplier reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by $0.02. The firm had revenue of $11.70 million during the quarter, compared to analyst estimates of $11.49 million. Mazor Robotics had a negative return on equity of 30.90% and a negative net margin of 45.08%. The business’s revenue was up 82.8% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.10) EPS. On average, analysts expect Mazor Robotics to post $-0.89 EPS for the current fiscal year and $-0.55 EPS for the next fiscal year.
Mazor Robotics Ltd. (MZOR) traded down 4.20% during midday trading on Thursday, hitting $38.99. The company had a trading volume of 148,493 shares. Mazor Robotics Ltd. has a 12-month low of $19.75 and a 12-month high of $45.64. The stock’s market cap is $930.89 million. The company’s 50 day moving average is $36.81 and its 200 day moving average is $31.16.
Several brokerages recently commented on MZOR. JMP Securities cut Mazor Robotics from an “outperform” rating to a “market perform” rating in a report on Friday, May 12th. They noted that the move was a valuation call. Needham & Company LLC reaffirmed a “hold” rating on shares of Mazor Robotics in a report on Thursday, July 6th. Ladenburg Thalmann Financial Services reaffirmed a “buy” rating and issued a $46.00 price target on shares of Mazor Robotics in a report on Monday, June 12th. Zacks Investment Research cut Mazor Robotics from a “hold” rating to a “sell” rating in a report on Tuesday, July 18th. Finally, Standpoint Research cut Mazor Robotics from a “buy” rating to a “reduce” rating and dropped their price target for the company from $32.98 to $28.00 in a report on Wednesday, April 19th. They noted that the move was a valuation call. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the company’s stock. Mazor Robotics has a consensus rating of “Hold” and an average price target of $33.50.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.